Press "Enter" to skip to content

P.T.A.B. Grants Bausch & Lomb’s Request to Review ZeaVision Patents on Zeaxanthin Formulations to Protect Human Eye Cells from Harmful Ultraviolet Light

The U.S. Patent Trial and Appeal Board granted Bausch & Lomb Incorporated’s petition for inter partes review of U.S. Patent No. 11,173,133 B2 controlled by…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.